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More than a decade has elapsed since the link between the endosomal sorting complex required for transport (ESCRT) machinery
and HIV-1 protein traﬃcking and budding was ﬁrst identiﬁed. L domains in HIV-1 Gag mediate recruitment of ESCRT which
function in bud abscission releasing the viral particle from the host cell. Beyond virus budding, the ESCRT machinery is also
involved in the endocytic pathway, cytokinesis, and autophagy. In the past few years, the number of non-ESCRT host proteins
shown to be required in the assembly process has also grown. In this paper, we highlight the role of recently identiﬁed cellular
factors that link ESCRT machinery to calcium signaling machinery and we suggest that this liaison contributes to setting the stage
for productive ESCRT recruitment and mediation of abscission. Parallel paradigms for non-ESCRT roles in virus budding and
cytokinesis will be discussed.
1. Focus of This Paper
Determinants intrinsic to the structural precursor polypro-
tein (Gag) that is encoded by the Human Immunodeﬁciency
Virus-type 1 (HIV-1) and other retroviruses direct targeting
of Gag to the plasma membrane, membrane and genome
RNA binding, Gag multimerization, and budding of the
assemblage into the extracellular space as virus particles
(reviewed in [1–4]). Through a proteomic search aimed at
identiﬁcation of cellular factors that might participate with
GagandESCRT,weidentiﬁed theinositol 1,4,5-triphosphate
receptor (IP3R) as a protein enriched in an endosome-
and plasma-membrane-enriched fraction [5] only when
Gag was expressed (unpublished observation). IP3R protein
forms a transmembrane calcium ion (Ca2+) channel that
is mostly found on the membrane of the endoplasmic
reticulum (ER), the major intracellular Ca2+ store in the
cell. IP3R has also been detected on the plasma membrane,
late endosome/multivesicular bodies (LE/MVBs), and the
nucleus (reviewed in [6–8]). Eﬃcient HIV-1 Gag traﬃcking
and viral particle release were shown to require activation of
IP3R [9]. IP3R activation requires phospholipase-C- (PLC-)
catalyzed hydrolysis of PI(4,5)P2 to generate inositol 1,4,5-
triphosphate (IP3), the activating ligand for the receptor
(reviewed in [6–8]). Binding of IP3 initiates conformational
changes leading to channel opening and release of Ca2+ into
the cytosol [10]. Earlier studies on HIV particle production
had demonstrated that induction of a transient rise in the
cytosolic Ca2+ concentration resulted in a dramatic rise
in viral particle release, suggesting that Ca2+ is a limiting
factor in late-stage replication [11, 12]. Taken together, these
observations collectively suggested that IP3R is the physio-
logical provider of the required Ca2+. The proteomic search
also identiﬁed several additional proteins that function in
regulation of Ca2+ signaling, including Sprouty2 (Spry2),
a modulator of Ca2+ signaling [13] and other modes of
signaling [14, 15]. We demonstrated that Spry2 is also
required for productive HIV egress [16, 17]. Proteins such
as IP3R and Spry2 have been shown to function with the
same elements of cytoskeletal and vesicular transport that
are integral to ESCRT machinery [18–20]. Over the past few
years,anumberofothernon-ESCRThostproteinshavebeen
shown to be required for Gag assembly. Some of these have
been discussed in recent reviews [2, 21, 22]. We will discuss2 Molecular Biology International
how these host proteins set the stage for ESCRT recruitment
and ESCRT-mediated abscission events. We apologize to
those investigators whose studies may be pertinent but were
not explicitly cited.
2.Introduction
Enveloped viruses, like HIV-1, exit the host cell by budding.
The segment of the plasma membrane that serves as
assembly platform evaginates to form the budded particle
and becomes the viral envelope. Since the Gag precursor is
the viral gene product that plays the key role in recruiting
other viral components to the assembly site [23, 24], the
assembly process must necessarily include a mechanism for
stable localization of Gag at the plasma membrane (PM).
Once on the PM, Gag has intrinsic assembly capability that
is attributed to functions of its four domains (matrix-capsid-
nucleocapsid-p6). The N-terminal matrix (MA) domain
mediates membrane binding ([25–29] and references in
[1]). The capsid (CA) domain provides Gag with capability
for self-assembly into higher-order multimers ([30–35]a n d
references in [36]). The nucleocapsid domain (NC) mediates
binding to viral RNA and nonspeciﬁc RNAs as well as
promoting Gag association [37–39] and references in [40].
The C-terminally located p6 region mediates the untethering
of the assembled Gag particle from the host [41, 42].
Orderly cleavage of Gag at interdomain junctions within
the structural precursor polyprotein by a virus-encoded
proteinase [43–47] occurring concurrently with budding
results in mature proteins whose rearrangement transforms
the bud to a mature, infectious particle [48, 49]. The ﬁnal
step of the virus assembly process, which results in the
pinching oﬀ of the particle from the host cell, is mediated
by ESCRT proteins that have been recruited to the bud neck
by motifs in p6 that are designated as “late” or L domains
(reviewed in and references in [50, 51]). Thus, Gag is both
necessary and suﬃcient for viral particle assembly [52].
3.PlasmaMembrane Targeting:
Role of PI(4,5)P2
As a cytosolic protein, the synthesis of Gag takes place on
soluble polysomes in the cell interior [53]. A myristoylation
reaction occurs cotranslationally during which Gag acquires
a myristoyl moiety on the N-terminal glycine which plays
a role in assembly [28, 54, 55]. At the earliest experi-
mentally feasible time points, Gag has been demonstrated
to have a cytosolic distribution when examined by con-
focal microscopy [11], biochemical fractionation [56], and
immunogoldelectronmicroscopy[57].Eventually,theentire
Gag population becomes membrane associated with the PM
asthepreferredsiteatsteadystate(referencesin[23]).Thisis
consistent with the results of in vitro binding studies wherein
MA, which is highly basic ([25–29] and references in [1]),
mediates binding to membranes reconstituted with acidic
phospholipids ([26, 27] and references in [1]). It is also
consistent with observations that the cytoplasmic leaﬂet of
the PM is unique among cell membranes in having a net
negative charge due to high levels of acidic phospholipids
[58]. The targeting phospholipid was identiﬁed as the
complex acidic phospholipid, phosphatidylinositol 4,5 bis-
phosphate (PI(4,5)P2)[ 59]. Depletion of PI(4,5)P2, using
plasmamembrane-targeted lipid phosphatases, caused Gag
to be localized to LE/MVBs and prevented Gag localization
to the PM [59]. PI(4,5)P2 is mostly found on the PM where
it represents a minor plasma membrane lipid component
[60]. Structural analysis of PI(4,5)P2 binding to HIV-1 MA
shows contacts made by the head group (i.e., phosphates
and inositol ring) with basic residues and the nestling of
adjacent acyl groups into a hydrophobic cleft [61] while
studies with full-length Gag underscored the importance
of the phosphoinositide acyl chain [62]. These in vitro
studies also predict initiation of Gag structural changes
following PI(4,5)P2 binding. Studies with the matrix protein
show that PI(4,5)P2 binding results in exposure of the N-
terminal myristate [61]. Studies with Gag in the presence
of nucleic acid reveal an interplay between binding to
PI(4,5)P2, binding to nucleic acid, and capsid (CA) domain-
mediated self-association [63]. The model of Gag membrane
association founded on Gag interaction with PI(4,5)P2 is
supported by the inhibitory eﬀect on Gag particle release
of depletion of plasma membrane PI(4,5)P2 [59, 64, 65]. It
should be noted that as important as PI(4,5)P2 is to HIV-
1 Gag membrane targeting, the importance of PI(4,5)P2 to
targeting and release of other retroviral Gags varies. Mo-
MLV exhibits a preference and a requirement for PI(4,5)P2
[66]. Equine infectious anemia virus (EIAV) budding is
less impacted by depletion of PI(4,5)P2 due to preferential
binding to PI(3,5)P2 [65]. PI(3,5)P2 is a phospholipid that
is predominantly associated with endosomal compartments
at steady state [67] implying endosomal targeting of EAIV
Gag in the cell. EIAV Gag traﬃcking requires such targeting
as inactivation of the PI(3)P2 5-kinase, which is responsible
for the endosomal placement of PI(3,5)P2 [67], inhibits
EIAV Gag VLP production [65]. ASV budding appears
to rely on electrostatic interaction with acidic phospho-
lipids and exhibits no speciﬁc reliance on phosphoinositide
components of the PM [68]. Thus, HIV-1 Gag membrane
association is mediated by a speciﬁc bipartite determinant
in the MA domain comprised of myristate and basic amino
acid clusters [1] with Gag-PI(4,5)P2 binding serving as the
basis for targeted membrane association. Gag’s preferential
associationwiththeplasmamembraneisduetotwoinherent
features of PI(4,5)P2: (i) the PM is where most of cellular
PI(4,5)P2 is located [60] and (ii) PI(4,5)P2 molecules are
products of in situ synthesis (i.e., PM-localized molecules
are produced at the PM; [69]). Thus, PI(4,5)P2 targeting
provides a mechanism to direct Gag from its site of synthesis
in the cell interior to the plasma membrane.
Detection of assembled HIV-1 Gag inside membrane
compartments with the characteristics of LE/MVBs has
been documented [70, 71], and altered Gag residency in
LE/MVBs following stimulatory or inhibitory eﬀects on
virus production has been demonstrated [11, 72, 73]. Addi-
tionally, the virus particle has components that are typical
exosome markers [74]. However, for macrophages, at least,
those apparently intracellular membrane compartmentsMolecular Biology International 3
with LE/MVB features were demonstrated to be actually
extracellular space delineated by intracytoplasmic plasma
membrane [75, 76]. Moreover, Gag particle production has
been shown to be insensitive to interference with LE/MVB
function [77]. The role of the LE/MVB in Gag assembly and
releasethusremainscontroversial.Wesuspectthatattheroot
of this controversy is the complex nature of the LE/MVB
itself. It cannot be precluded that the endosomal machinery
can interact with Gag in the traditional manner, wherein
ESCRT machinery facilitates sorting of cargo proteins into
MVBs for ultimate delivery to degradative compartments.
However, the handling of sorted proteins by the MVB is
not always unidirectional. Though targeted to the LE/MVB
in both HeLa and Jurkat cells, the 29KE/31KE Gag mutant
is released at near wild-type levels from Jurkat cells but is
trapped inside HeLa cells [78] which shows that traﬃcking
within the MVB can be inﬂuenced by its environment
(i.e., cell dependence). EIAV Gag is another interesting
case since, despite its endosomal targeting, EIAV Gag VLPs
are released from cells such as COS-1 and HeLa [65]. It
would be interesting to know if EIAV Gag induces any
alteration in the MVB and, if so, whether this facilitates
productive infection. Direct delivery of Gag to the site of
release on the plasma membrane circumvents the potentially
nonproductive outcome of Gag association with endosomal
machinery. A Gag assembly model that incorporates Gag-
PI(4,5)P2-based targeting of Gag to assembly sites on the PM
permitsamoreproductivepathfromGagsynthesistorelease
of an assembled Gag particle.
4.LateDomainsinGagRecruit
ESCRTMachinery
Budding structures accumulate on the plasma membrane if
the C-terminal p6 region is missing from Gag [41, 42]. The
p6 region bearing the L domain has counterparts in other
retroviruses and is functionally exchangeable with these
within and outside the genera; for example, the PTAP motif
from the p6 region of HIV-1 Gag was shown to substitute
for the PY motif in the L domain-bearing region (p2b) of
the avian sarcoma virus (ASV) and vice versa [79–83]a n d
references in [50, 51, 84, 85]. Functional exchangeability
demonstrates that there are multiple, though not necessarily
equally eﬀective, ways for Gag to access the ESCRT machin-
ery. Accordingly, Tsg101 as binding partner of the HIV PTAP
motif and Nedd4 family members as binding partner of the
ASV PY motif facilitate release of HIV-1 and ASV, respec-
tively, through functionally exchangeable but independent
routes (i.e., Tsg101 can replace Nedd4 function in facilitating
ASV budding [86, 87]). Members of the Nedd4 family of
ubiquitin ligases can also replace Tsg101 in facilitating HIV-1
release under certain circumstances [88–91]. The binding
of the ESCRT adaptor, Alix, to the secondary L domain
in Gag serves this purpose as well (reviewed in [92]). The
ESCRT machinery is now known to comprise >25 proteins,
organized into four complexes (ESCRT-0, -I, -II, and -III)
that function sequentially along with several additional
associated factors (reviewed in [93–95]). Irrespective of how
Gag is linked to the ESCRT machinery, in all cases ESCRT-III
andVps4mustberecruitedtothebudneckatthemembrane
site to execute the ﬁnal bud scission event and to release the
ESCRT factors from the assemblage for recycling back to
the cytosolic pool for participation in future events [96, 97].
A feature of retroviral utilization of the ESCRT machinery
is the selective use of the ESCRT complexes. HIV-1 viral
particle production requires ESCRT-I and ESCRT-III but
not ESCRT-II [98] while ASV requires ESCRT-II but not
ESCRT-1 [99]. These observations, along with recognition
that ESCRTs, which normally function in transport of some
cellular proteins to degradative cellular compartments, are
requiredforexitofassembledGagfromthecell,suggeststhat
non-ESCRT host proteins may play a key role in allowing
the ESCRT machinery to be utilized diﬀerentially by the
virus compared to the host. Thus, non-ESCRT proteins may
permit HIV to exploit ESCRT machinery by preventing the
Gag-ESCRT complex from participating in interactions with
ESCRT partners that are nonproductive for the virus.
5.ParallelsbetweenHIV-1 Budding,
Cytokinesis,andAutophagy
“All organisms do things the same way except that
it is completely diﬀe r e n ti ne v e r yd e t a i l ”J .H a b e r
The abscission event in virus budding results in sepa-
ration of the enveloped virus from the host cell. Another
process where the abscission event results in separation
of two membrane-enclosed cellular entities is cytokinesis.
Cytokinesis, itself a multistep process, is the terminal
stage in cell division [100]. Abscission of the intercellular
bridge/midbody results in separation of the mitotic daughter
cells. Recruitment of ESCRT and mediation of the abscission
event by ESCRT is the basis for the parallel between HIV-
1 budding and cytokinesis [101, 102]. The parallel may
extend to events occurring before ESCRT recruitment and
participation, (i.e., in a pre-ESCRT stage). Paradigms that
govern the pre-ESCRT stage of cytokinesis, which has been
an active area of research long before discovery of HIV, may
likewise apply to the pre-ESCRT stage of viral budding.
Athemethatisemergingasacellpreparesforcytokinesis
is the reshaping of calcium signaling [103]. Local and global
elevations in cytosolic Ca2+ level are achieved by ion release
from the ER (the cell’s major intracellular Ca2+ store) and
by inﬂux from the extracellular environment [104]. Decrease
in Ca2+ content of the ER triggers activation of Ca2+ inﬂux
channels on the plasma membrane and reﬁlling of the
ER store in a process called store-operated-calcium-entry
(SOCE) [105, 106]. A major cellular change that occurs
during cell division prior to cytokinesis is the uncoupling
of Ca2+ store depletion and SOCE [107, 108]. Why this
is necessary is presently not known but the eﬀect is to
render the pre-ESCRT events in cytokinesis independent
of SOCE and reliant on the internal stores as the Ca2+
source. Independence from SOCE and reshaping of calcium
signaling as a pre-ESCRT stage paradigm also appear to
be the case for HIV-1 budding. Blockade of SOCE with
2-aminoethoxydiphenylborate (2-APB), a small molecule4 Molecular Biology International
inhibitor of store reﬁlling through SOCE [109], had no
eﬀect on release of the HIV-1 Gag particle [110]. Blockade
of a G protein-coupled receptor cascade [111]t r i g g e r e d
by Ca2+ entry through receptor-operated calcium entry
(ROCE; [112]) also had no eﬀect on Gag particle release
[110]. Additionally, cells where productive Gag budding is
occurring (i.e., expression of wild-type Gag) exhibit higher
cytosolic Ca2+ compared to mock-transfected cells or cells
expressing a budding-impaired PTAP Gag mutant [110].
Possibly, insulating the calcium machinery from external
Ca2+ sources allows both virus budding and cytokinesis to
proceed more eﬃciently. Figure 1 shows the elements of the
Ca2+ signaling machinery implicated in HIV-1 release.
Cytokinesis and viral budding share several general
features (Figure 2) .T h eﬁ r s ts t e pi nb o t hp r o c e s s e si s
the targeting of the requisite components to the eventual
scission site, that is, the plasma membrane. Formation
of the cleavage furrow is a visual marker of initiation of
cytokinesisandaspectsofthiseventthatappearsimilartothe
budding process are furrow ingression, that is, a progressive
narrowing of the eventual scission region to form a bud
neck. In cytokinesis, the separating bodies are of comparable
volumes; in viral budding, they are of unequal volumes.
IP3R, intact PI(4,5)P2, PI(4,5)P2 hydrolysis, and Ca2+ are
all required for the normal progression of cytokinesis in
cellular systems where cell division has been well studied,
for example, spermatocyte and oocytes [113–116]. There is
ar e q u i r e m e n tf o rC a 2+ to maintain furrow or neck stability,
necessitating constant PLC-mediated hydrolysis of PI(4,5)P2
[117, 118]. Components involved in Ca2+ mobilization and
cytoskeleton remodeling are recruited to the furrow [117–
119]. Similarly, in addition to intact PI(4,5)P2 [59], HIV
budding requires IP3R and PLC activity [9, 110]. Analogous
to IP3R recruitment to the furrow in cytokinesis, there is
also recruitment of IP3R to Gag budding sites on the plasma
membrane [110].
In cytokinesis, the non-ESCRT protein mediating re-
cruitment of ESCRTs is Cep55. Cep55 recruits Tsg101, a
component of ESCRT-I, and Alix, an ESCRT adaptor protein
that binds both ESCRT-1 and ESCRT-III, to the eventual
scission site once furrow ingression is completed [101, 102,
122–124]. These ESCRT factors, in turn, recruit the ESCRT-
III complex required to carry out the terminal step in cytoki-
nesis, abscission, that is, the severing of the thin intercellular
bridge that connects the two daughter cells [125–127]. The
counterpart of the Cep55-ESCRT link in viral budding is the
targeting of Gag to the eventual scission site on the plasma
membrane and recruitment of Tsg101 and/or Alix through
the L domains and eventually ESCRT-III.
Autophagy, the process involved in the breakdown of
intracellular proteins and organelles, is now appreciated as a
mechanism of great importance in both cell survival and cell
death [128]. It is the latest cellular process linked to ESCRT
function. Indeed, autophagy is a necessary postabscission
step in cytokinesis [129]. Following cytokinesis, the dividing
cells are connected by an intracellular bridge that contains
the midbody. This structure persists long after division as a
midbody derivative that is inherited asymmetrically by the
daughter cell with the older centrosome. Recent ﬁndings in
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Figure 1: Elements of Ca2+ signalingmachinery implicated inHIV-
1 release. Tsg101-mediated release requires the core elements, IP3R,
PI(4,5)P2,andPLC.Alix-mediatedreleaserequiresthese,SOCEand
ROCE. It is not known whether SOCE and ROCE are controlled
by distinct Ca2+ channels [120] or if the same channel complexes
mediate SOCE when recruited to lipid rafts and ROCE when they
are outside of lipid rafts [121].
mammalian cells and in Drosophila melanogaster indicate
that ESCRTs are required for eﬃcient traﬃcking through
the endolysosomal system where the autophagic cargo is
degraded [130–132]. As with cytokinesis and viral budding,
IP3R-mediated Ca2+ signaling is emerging as critical for the
pre-ESCRT stage in autophagy [133]. De novo synthesis of
phospholipids is coupled with autophagosome formation
[134].PairingphosphoinositideswithCa2+ ionsinendolyso-
somes has been suggested to control the direction and
speciﬁcityofmembranetraﬃcking[135].Allthreeprocesses,
cytokinesis [136], viral budding [137], and autophagy [138,
139], require or involve SNAREs to conduct some of the
critical events. The participation of calcium machinery com-
ponents in all three processes suggests that the requirement
for and reshaping of calcium signaling is a common feature
governing their pre-ESCRT stages.
6.Non-ESCRTProteinsandOther
FactorsEngagedinthe Pre-ESCRT
Stages of HIV-1 Assembly
For a number of non-ESCRT host proteins shown to
be important for release of the Gag particle [2, 4, 22,
140], disruption of the protein function does not result in
the canonical L domain phenotype (i.e., arrested budding
structures at the periphery of cells examined by EM). Rather,
Gag is found in the cell interior. We and others [2] interpret
this to indicate participation of these proteins in assembly
step(s) preceding ESCRT-mediated budding. Some of these
proteins have regulatory links to each other. Among these
are the human vacuolar protein sorting (hVps) protein 18
(Vps18),aclassCVpscomplexcomponent,andMon2.Both
have been shown to be required for Gag PM localizationMolecular Biology International 5
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Figure 2: Similarities between cytokinesis (top) and viral particle production (bottom). CF: cleavage furrow. EM image shows HIV-1 VLPs
in the process of budding. Bars indicate 100 nm.
and virus production [141]. In yeast, class C Vps proteins
have been shown to regulate PM localization of at least one
protein [142] and to assume roles antagonistic to ESCRT
in the recycling of membrane proteins [143]. The human
orthologue of Mon2 (hMon2) can bind and regulate the
subcellularlocalizationofadaptorproteinssuchasAP-1,AP-
3, and Arf1 which have previously been shown to be required
for Gag PM localization and Gag particle production [72,
144, 145]. The notion of non-ESCRT proteins regulating the
activityofothernon-ESCRTproteinsinthepre-ESCRTstage
has a parallel in cytokinesis as illustrated by the host protein,
TEX14. This non-ESCRT protein binds Cep55 at the same
motif used to recruit Tsg101 or Alix and negatively regulates
ESCRT recruitment [146]. Through protein-protein interac-
tions, non-ESCRT proteins could thus impose temporal and
spatial control of the recruitment of participating proteins,
including Gag itself, to assembly sites on the PM during the
pre-ESCRT stage.
Another pre-ESCRT event is alteration of the lipid com-
position of the assembly site. Quantitative analyses indicate
that the viral envelope diﬀe r sf r o mt h eP Mo fi t sh o s tc e l li n
having higher levels of cholesterol and PI(4,5)P2 [58, 147].
SincetheviralenvelopeisderivedfromthePMmicrodomain
serving as the Gag assembly site, reorganization of the lipid
bilayer in this location may occur as part of the assembly
process.AfeatureofPMPI(4,5)P2 isthatthegreatermajority
is sequestered by electrostatic interaction with basic proteins
that are resident at the PM (e.g., myristylated alanine-rich
C kinase substrate (MARCKS; growth-associated protein
(GAP)43; N-methyl-D-aspartate (NMDA) receptor, and
the epidermal growth factor receptor (EGFR)) and is only
released by a local rise in Ca2+ [148]. Another property of
PI(4,5)P2 is that it does not have a natural inclination for
clustering due to the energy barrier posed by repulsion of
the large polar head groups when they are in proximity.
It has been shown that Ca2+ can reduce this barrier and
induce PI(4,5)P2 clustering in lipid monolayers [149].
Recruitment of IP3R machinery to the cell periphery and
release of Ca2+ may function to increase the portion of
PM PI(4,5)P2 available for interaction with Gag and to
permit the clustering of PI(4,5)P2 molecules upon Gag
multimerization. This model is summarized in Figure 3 and
may explain how the budding requirement for both intact
and hydrolyzed PI(4,5)P2 could be simultaneously resolved.
That budding structures are still formed by Gag mutants
with disrupted PTAP motifs despite their impairment in
recruitment of Tsg101 or in cells where Tsg101 has been
depleted [50, 51] indicates that assembly site membrane
deformation is a pre-ESCRT stage event. Although not
required for initiation [116], Ca2+ is required for furrow
ingression and for stability of the intercellular bridge in
cytokinesis [113–116]. Furrow ingression in the presence
of Ca2+ leads to a productive ESCRT recruitment stage as
indicated by completion of cytokinesis. Analogous to furrow
ingression is the formation of the virus bud neck where
the ESCRT scission complex is recruited. The fact that the
budding structures of Gag mutants with disrupted PTAP
motifs accumulate on the plasma membrane indicates a
failure in ESCRT recruitment even though the mutant has
been demonstrated to be capable of employing alternative
modes of linking to ESCRT (i.e., via Nedd4 or Alix). Our
study [110] shows that, in cells expressing HIV-1 Gag, IP3R
was translocated from the cell interior to the periphery and
colocalizedwithGagontheplasmamembrane.Interestingly,
IP3R redistribution is not induced in cells expressing the
PTAP Gag mutant even though release of the mutant, albeit6 Molecular Biology International
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Figure 3:Ca2+ facilitatesGag-PI(4,5)P2 interactionandstabilizationontheplasmamembrane.Top,thesquareshighlightthetop-downview
of the plasma membrane shown below. Bottom, (1) most of the PI(4,5)P2 on the plasma-membrane is sequestered with plasma membrane-
resident proteins that are highly basic and therefore unavailable to Gag. (2) A local rise in Ca2+ permits the cation to replace the resident
proteins, freeing the PI(4,5)P2 from these proteins. (3) PI(4,5)P2,m a d ea v a i l a b l eb yC a 2+, recruits Gag to the plasma membrane. (4) Gag
multimerization forms local PIP2 clusters that stabilize Gag association with the membrane, preventing loss of Gag from the narrowing bud
neck in preparation for ESCRT recruitment.
ineﬃcient, also requires IP3R-regulated machinery. The lack
of Ca2+ store recruitment, which IP3R recruitment signiﬁes,
to the cell periphery of cells expressing such mutants indi-
cates that, as is the case for furrow ingression, competency in
linking to ESCRT is a property of bud necks formed in the
presence of Ca2+.
The ability of the endoplasmic reticulum to form tubules
and small vesicles is what permits the stores to be recruited
[150]. Movement of IP3R-contaning ER vesicles along
microtubules has been shown to be facilitated by a kinesin
[151]. Kinesins are a large family of cellular protein motors
that use the energy of ATP hydrolysis to induce movement
along the microtubule [152]. Kinesins have been identiﬁed
as being involved in an intracellular process required for
Gag release: (i) Kinesin KIF4 was reported to bind Gag
directly through the MA domain [153]a n dw a sl a t e rf o u n d
to regulate intracellular traﬃcking and stability of Gag [154];
(ii) Kinesin KIF3, a binding partner of AP-3 shown to be
required for release of the viral particles assembled by Gag
[72], has also been reported to be involved in Gag release
[155]. Which particular kinesin is involved in IP3R transport
is unknown. Kinesin-mediated translocation of IP3R along
microtubuleswouldallowfordirecteddelivery ofCa2+ stores
to the budding site and, thereby, establish a localized region
where Ca2+ would be elevated. Thus, for Ca2+ provision,
utilization of the internal Ca2+ stores may provide a major
advantage over Ca2+ inﬂux which is mediated by channels
thatarehomogenouslydistributedontheplasmamembrane.
The notion that intact PI(4,5)P2 is required for targeting
Gag to the plasma membrane and that PLC-hydrolyzed
PI(4,5)P2 isrequiredforESCRT-recruitment-competentbud
neck ingression suggests the need for regulatory mechan-
isms that would ensure availability of the right form of the
phospholipid for the right event in the pre-ESCRT stage.
The “hydrolysis stimulates synthesis” model proposes that
hydrolysis and synthesis of PI(4,5)P2 are tightly coupled
events such that synthesis stimulates hydrolysis while
PI(4,5)P2 hydrolysis signals its production [69]. Ca2+ might
b eak e yr e g u l a t o r :C a 2+ is an activator of the lipid kinase
that is critical for PI(4,5)P2 synthesis [156] and of the PLC
that catalyzes PI(4,5)P2 hydrolysis [157]. However, Gag PM
targeting appears to require a more nuanced intact PI(4,5)P2
population. Although it has been clearly demonstrated that
depletion of PI(4,5)P2 with plasmamembrane-targeted lipid
phosphatases prevents Gag localization to the PM [59],
other experimental approaches give diﬀerent results. For
example, increased Gag PM targeting and VLP release were
not observed following a clear increase in PM PI(4,5)P2
in cells treated with a PLC inhibitor [9]. Also, a loss
of Gag PM targeting was reported in cells that did not
exhibit a detectable change in PI(4,5)P2 level or subcellular
distribution [145]. There is growing recognition that PM
PI(4,5)P2 exists in multiple pools and that the dynamic
nature of these pools is important for cellular processes
mediated by PI(4,5)P2 [148, 156]. Perhaps this conundrum,
that is, the lack of a clear correlation between Gag PM
targeting and the PI(4,5)P2 level, reﬂects a requirement for a
PI(4,5)P2 poolthatisspeciﬁcallymadeavailableforGag.The
non-ESCRT proteins, Spry2 and ADP-ribosylation factor-1
(ARF1),haveactivitiesthatmakethempotentialparticipants
in such regulatory mechanisms. Spry2 is required for Gag
particle budding [16, 17] and for production of infectious
virus (Ehrlich, Khan, Powell and Carter, unpublished obser-
vations). It has several activities that can aﬀect PI(4,5)P2
metabolism; namely, binding of phospholipase C [13]a n d
of PI(4,5)P2 [13, 17] and it can inhibit receptor-mediatedMolecular Biology International 7
activation of PLCγ [13]. Binding to PI(4,5)P2 exerted the
greatest inﬂuence on Gag particle production [17]. Involve-
ment of ARF-1 in Gag assembly was demonstrated by Joshi
etal.[145].Althoughthisprotein is bestknown foritsrole in
post-Golgi traﬃcking, ARF1 is also a stimulator of PI(4,5)P2
synthesis by directly activating PI(4)P 5-kinase and by
inducingformationofanenhancerofthekinase[158].Thus,
together with local Ca2+, Sprouty and ARF1 proteins have
the potential to ensure the dynamic existence of PI(4,5)P2
pools speciﬁcally made available for interaction with Gag.
Several other non-ESCRT proteins whose dysfunction
inhibitedtransportofGagfromthecellinteriortotheplasma
membrane may also be involved in Gag assembly as pre-
ESCRT stage participants. Admittedly, further studies will
be needed to elucidate their exact contribution; however,
interestingly, these proteins also have links to cytokinesis
and autophagy. In addition to the aforementioned SNARES
[145], these include citron kinase, a Rho eﬀector [159];
Rab9 [160] and other GTPases [161]; POSH [162]; AP-1
[144]; NPC-1 [73]; and Filamin A [163]. Direct participa-
tion in cytokinesis is documented for citron kinase, AP-1,
and Filamin A [164–166]. NPC-1 and POSH both aﬀect
the metabolism of two important factors in cytokinesis,
cholesterol [167], and calcium [168], respectively. Rab9 and
other small GTPases have been implicated in cytokinesis and
autophagy [118, 169].
7.Non-ESCRTProteinsin
the ESCRTRecruitmentStage
The formation of a Gag-Tsg101 complex occurs as part
of the Gag assembly process as long as L domain-1 is
intact. Although the precise stage at which Tsg101 docks
on the PTAP motif is not known, association after stable
bud neck formation might be more favorable as it precludes
nonproductive interactions with ESCRT-II that would signal
internalization of the Gag assemblage or premature ESCRT-
III scission. Spry2 forms complexes with components of
ESCRT-II [16]. Thus, Spry2 facilitates release driven by both
the primary and the secondary HIV-1 Gag L domains, pos-
sibly due to its ability to compete with ESCRT-I factors for
interaction with ESCRT-II components [16]. This notion is
consistent with the fact that HIV-1 budding does not require
ESCRT-II [98, 99]. Not surprisingly since the interaction
of ESCRT-I with ESCRT-II leads to cargo internalization, it
has been suggested that association with Tsg101 increases
susceptibility to internalization [170]. Delaying the recruit-
ment of ESCRT machinery to the budding site may provide
a means of maximizing viral budding eﬃciency. A parallel
to this as a regulation possibility in cytokinesis may be the
aforementioned function of TEX14, a protein believed to
control premature progression to the abscission stage by
competing with Tsg101 and Alix for binding to Cep55 [146].
8. Concluding Remarks
In this paper, we have focused on proteins involved in steps
in HIV-1 traﬃcking and budding that take place prior to
Gag recruitment of ESCRT machinery. As described here,
proteins that function in PI(4,5)P2 binding, synthesis or
hydrolysis,Ca2+ storerecruitment,IP3R-mediatedCa2+ store
release, and vesicular biogenesis or transport appear to
comprise the major classes of participants in the pre-ESCRT
stages. Cellular activities in almost all cells are regulated
by common signaling systems and Ca2+ is a ubiquitous
intracellular messenger that is known to control a diverse
range of processes. The discovery of Ca2+ signaling as a
cofactorinHIV-1proteintraﬃckingandrelease,itspotential
link to exploitation of the ESCRT machinery by the virus
for viral particle production, and the general similarity of
this coupling to other cellular activities in which ESCRTs
participate, that is, cytokinesis and autophagy, may provide
new therapeutic avenues for HIV treatment strategies.
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